RYZIMMU
Dead / Abandoned — Abandoned — no statement of use filed (as of 17 Sept 2018)
What this means for you
This application is over — abandoned 17 Sept 2018. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86713052
- Mark type
- Stylized text
- Filed
- 03 Aug 2015
- Published for opposition
- 22 Dec 2015
- Abandoned
- 17 Sept 2018
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations for the treatment of cancer and immune-suppressive diseases; Pharmaceutical preparations for the treatment of cancer and immune-suppressive diseases
Owner
- Argos Therapeutics, Inc., Durham, NC, US
- Argos Therapeutics, Inc., Durham, NC, US
Prosecution history
- 17 Sept 2018 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 17 Sept 2018 — ABANDONMENT - NO USE STATEMENT FILED
- 26 Jan 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Jan 2018 — SOU EXTENSION 4 GRANTED
- 24 Jan 2018 — SOU EXTENSION 4 FILED
- 24 Jan 2018 — SOU TEAS EXTENSION RECEIVED
- 10 Aug 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Aug 2017 — SOU EXTENSION 3 GRANTED
- 08 Aug 2017 — SOU EXTENSION 3 FILED
- 08 Aug 2017 — SOU TEAS EXTENSION RECEIVED
- 16 Feb 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Feb 2017 — SOU EXTENSION 2 GRANTED
- 14 Feb 2017 — SOU EXTENSION 2 FILED
- 14 Feb 2017 — SOU TEAS EXTENSION RECEIVED
- 13 Aug 2016 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED